Spectrum Pharmaceuticals, Inc.
SPPI · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $10,114 | $0 | $0 | $22,615 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $1,792 | $0 | $0 | $12,007 |
| Gross Profit | $8,322 | $0 | $0 | $10,608 |
| % Margin | 82.3% | – | – | 46.9% |
| R&D Expenses | $42,203 | $87,297 | $109,377 | $79,325 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $38,816 | $60,406 | $60,357 | $61,373 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$8,892 |
| Operating Expenses | $81,019 | $147,703 | $169,734 | $140,698 |
| Operating Income | -$72,697 | -$147,703 | -$169,734 | -$144,033 |
| % Margin | -718.8% | – | – | -636.9% |
| Other Income/Exp. Net | -$5,361 | -$10,729 | -$1,598 | $174,200 |
| Pre-Tax Income | -$78,058 | -$158,432 | -$171,332 | -$144,594 |
| Tax Expense | $46 | $4 | -$60 | -$9,208 |
| Net Income | -$78,104 | -$158,436 | -$171,272 | -$135,386 |
| % Margin | -772.2% | – | – | -598.7% |
| EPS | -0.43 | -1.02 | -1.38 | -1.22 |
| % Growth | 57.8% | 26.1% | -13.1% | – |
| EPS Diluted | -0.43 | -1.02 | -1.38 | -1.22 |
| Weighted Avg Shares Out | 183,237 | 154,862 | 124,387 | 110,586 |
| Weighted Avg Shares Out Dil | 183,237 | 154,862 | 124,387 | 110,586 |
| Supplemental Information | – | – | – | – |
| Interest Income | $968 | $163 | $1,342 | $4,996 |
| Interest Expense | $998 | $0 | $0 | -$4,996 |
| Depreciation & Amortization | -$4,363 | $286 | $261 | $3,335 |
| EBITDA | -$77,060 | -$147,417 | -$169,473 | -$154,586 |
| % Margin | -761.9% | – | – | -683.6% |